The PRONTO amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 2b study of NEOD001 in previously treated subjects with light chain amyloidosis and persistent cardiac dysfunction Meeting Abstract
| Authors: | Merlini, G.; Liedtke, M.; Landau, H. J.; Comenzo, R. L.; Sanchorawala, V.; Weiss, B. M.; Zonder, J. A.; Schonland, S.; Guthrie, S. D.; Walling, J.; Kinney, G. G.; Koller, M.; Gertz, M. A. |
| Abstract Title: | The PRONTO amyloidosis study: A randomized, double-blind, placebo-controlled, global, phase 2b study of NEOD001 in previously treated subjects with light chain amyloidosis and persistent cardiac dysfunction |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 434s |
| Language: | English |
| ACCESSION: | WOS:000404711505228 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS8073 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS8073 -- Source: Wos |
